Press Releases

Delegates from European Parliament Express Support for Rapid Development of New TB Vaccine

...

Emergent BioSolutions to Release Fourth Quarter and Full Year 2010 Financial Results and Conduct a Conference Call on March 10, 2011

...

Emergent BioSolutions Announces Initiation of Phase Ib/II Study of TRU-016 in Combination with Bendamustine for Chronic Lymphocytic Leukemia

...

Emergent BioSolutions Provides Preliminary 2010 Financial Results and Guidance for 2011

...

Emergent BioSolutions Starts Phase I Clinical Trial for Third Generation Anthrax Vaccine

...

Emergent BioSolutions to Webcast Presentation at JPMorgan Healthcare Conference

...

Emergent BioSolutions Presents Positive Data from Its TRU-016 Program at American Society of Hematology Meeting

...

Emergent BioSolutions Awarded Five Therapeutic Discovery Project Grants

...

Emergent BioSolutions Announces Acceptance of TRU-016 and TRU-Adhance Abstracts for Presentation at American Society of Hematology Meeting

...

Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences

...

Emergent BioSolutions Reports Financial Results for Third Quarter and First Nine Months of 2010

...

Emergent BioSolutions Receives Orphan Drug Designation for Its Investigational Monoclonal Antibody for the Treatment of Inhalation Anthrax

...